Danish Medicines Agency The European Commission has reached a decision in the case about the bioequivalence company Synchron Research, deciding that a number of generic medicines must be suspended in the EU counties where they are authorised. The Danish Medicines Agency therefore suspends the marketing authorisations of four medicines. Go to Source December 13, 2022 […]Continue reading

error: Content is protected !!